|








|
Tatjana E
Kisina
52-30 Industrialny prospect,
Saint-Petersburg, Russia, 195279
Tel: +7(812)234-16-69 (work)
Tel: +7(812)393-86-55 (home)
E-mail: tkissina@yandex.ru
BIRTHPLACE AND DATE Saint
Petersburg, November 10, 1978
EDUCATION
2002-2005: PhD student, 3rd year, Saint Petersburg State University,
Russia.
2000-2002: M.D., Saint Petersburg State University, Russia.
Major: immunology
1996-2000: B.S., Saint Petersburg State University, Russia.
Major: biology
PROFESSIONAL EXPERIENCE
2001-2005:
Junior Research scientist of the Department of Immunology in the
Experimental medicine institute, RAMS, Russia. Junior Research scientist
of the Laboratory of TB Immunology in the Scientific Research Institute of
Phtisiopulmonology, Ministry of Health, Russia. Wrote M.D. thesis on the
granulocyte activities in TB patients and a possibility of their defects
correction with immunomodulator Likopid. Now studying flow cytometer
methods, making PhD theses.
1999-2001:
Laboratory assistant, clinical immunology laboratory, National center of
emergency and radiation medicine of EMERGCOM of Russia. Studied
immunology, trained in diagnostic methods, wrote B.S. degree work on the
correlation between TNF levels and neutrophils functional activity.
1996-2000:
Student, Saint-Petersburg State University, Biology and Soil Sciences
Faculty, Department of Cytology and Histology. In parallel with studying
at the University trained in histological tissue preparations, molecular
biology methods (PCR, DNA and protein electrophoresis), has written a term
work on the TCR and Ig diversity formation mechanisms.
ACTIVITIES
Skills
Laboratory techniques: cell fractioning and cell culture, ELISA, flow
cytometer, PMN and lymphocyte functional analysis, molecular biology
methods, circulating immune complexes assay.
Computer skills: advanced PC and Mac user, Windows, MS Office,
Internet-user.
Foreign languages: English – fluent.
Publications:
1. Irina S. Freidlin, Ela A. Starickova, Evgueni I. Amtchislavski, Dmitri
I. Sokolov, Tatyana E. Kisina, Sergei A. Selkov. Cytokine Control of
Interaction of Endothelial cells EA.hy926 with Monocytic Cells U-937 in an
In Vitro Coculture System // Clinical and Investigative Medicine. 2004.
Vol. 27. N.4. P. 53B
2. Kisina Ò.Å., Freidlin I.S., Knoring B.Å., Archakova L.I., Basek Ò.S.,
Elkin À.V., Skvortsova L.À. Characteristics of lymphocyte phenotype in TB
patients according to their proliferative response to PPD // Medical
Immunology.- 2004.- Vol.6, ¹3-5. - P.312-313
3. Kisina Ò.Å. Phenotyping of circulating lymphocytes in patients with
different forms of pulmonary tuberculosis. // Medical Academic Journal –
2004.- Vol.4, ¹3. – P.45
4. Kisina Ò.Å. Peripheral blood lymphocyte subsets in patients with
pulmonary tuberculosis // Abstracts of international conference in Odessa
State Medical Univercity “Scientists of tomorrow”. – 2004. - P.35
5. Kisina Ò.Å., Freidlin I.S., Knoring B.Å., Basek T. S., Elkin À.V.,
Andronova Ò.Ì. The in vitro influence of immunomodulator likopid on the
peripheral blood granulocytes of tuberculosis patients // Medical Academic
Journal – 2004. – Vol.3, ¹4.- P. 29-38
6. Kisina T. E., Knoring B. E., Elkin A. V., Basek T. S., Archakova L. I.
Dynamic changes of PMN functional activity in tuberculosis patients. 6th
John Humphrey advanced summer programme in immunology: abstracts. - 2002.-
p.56-57
7. Kisina T. E., Knoring B. E., Elkin A. V., Basek T. S., Archakova L. I.
Changes of neutrophil functional activity in tuberculosis patients during
the treatment. // Medical Immunology – 2002. – Vol.4, ¹2. – P.239.
8. Kisina Ò.Å., Knoring B.Å., Kalinina N.Ì., Archakova L.I., Basek T. S.,
Neutrophil functional activity in patients with pulmonary tuberculosis //
Medical Immunology – 2001. – Vol.3, ¹2. – P.221.
9. Kisina Ò.Å., Bachtin M.Yu., Syssoev Ê.À., Kalinina N.Ì. Study of TNF-mediated
relations between immune system and neutrophilic granulocytes // Russian
Journal of HIV/AIDS and related problems – 2000. – Vol.4, ¹1. – P.109.
(March 2006)
Brief description of current work of
Tatjana Kisina.
My scientific interests lay in the
field of innate immunity and immune regulation under physiologic
conditions and in disease, in particular during tuberculosis. Containment
and cure of tuberculosis requires an effective cell-mediated immune
response, and the absence, during active tuberculosis infection, of
delayed type hypersensitivity responses to M. tuberculosis antigens,
defined as anergy, is associated with poor clinical outcome. It’s known
that proliferative response to M.tuberculosis antigens is decreased in
some tuberculosis patients. Recently regulatory suppressor cells were
found in such persons. We have shown that, failure in lymphocyte
functional response to tuberculin is accompanied by increased counts of
CD3+CD16+CD56+ (NKT) and CD3+CD8+ cells. Maintenance of functional
response to PPD is combined with increased CD3-HLA-DR+ numbers.
At present time I study an in vitro influence of IFNg and M. tuberculosis
PPD (tuberculin) on NBT-test induction in PBMCs from healthy persons and
PPD-normal and PPD-anergic TB patients. To date, we showed a decrease of
NBT-reducing capacity in response to IFNg and PPD in most TB patients. The
study comprises estimation of cytokine levels (preliminary IL-10 and IFNg)
and phenotyping of blood monocytes for CD14 and CD16. Together with that I
participate in collaboration project “Genetic study of normal and
susceptible TB patients” of Max Planck Institute of Infection Biology
(Berlin) and Institute of Phtisiopulmonology (Saint-Petersburg).
|